Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 05:37 am
Share
Wellbiotec Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 14,599.82 million compared to KRW 7,355.05 million a year ago. Net loss was KRW 81.34 million compared to KRW 5,757.94 million a year ago. Basic loss per share from continuing operations was KRW 1 compared to KRW 96 a year ago. Diluted loss per share from continuing operations was KRW 1 compared to KRW 96 a year ago. Basic loss per share was KRW 1 compared to KRW 102 a year ago.
For the six months, sales was KRW 41,774.71 million compared to KRW 12,924.94 million a year ago. Net income was KRW 3,602.91 million compared to net loss of KRW 7,835.36 million a year ago. Basic earnings per share from continuing operations was KRW 58 compared to basic loss per share from continuing operations of KRW 144 a year ago. Diluted earnings per share from continuing operations was KRW 58 compared to diluted loss per share from continuing operations of KRW 144 a year ago. Basic earnings per share was KRW 58 compared to basic loss per share of KRW 150 a year ago.
WELLBIOTEC CO.,LTD, formerly YBROAD CO., LTD., is a Korea-based company engaged in the leather business. The Companyâs products portfolio consists of nappa, naked, soft and other types of leathers used for handbags; water proof, gore-tex, nubuck, white and washable leathers used for shoes; chrome and non-chrome leathers used for car seats; chrome and non-chrome, and grain leathers used for steering wheels, and others, including baseball glove leathers and belt leathers. It also involves in the integrated transportation business, as well as wholesale and retail of electrical equipment business through its subsidiaries. The Company supplies its leather products to Coach, Tumi, Juicy, Vicotornox, Brighton, Timberland, Foot Joy, Stride Rite, Honda, Acura, Suzuki, Toyota and others.